De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia likely results from poorly understood genetic and environmental factors. We studied the gene encoding the synaptic protein SHANK3 in 285 controls and 185 schizophrenia patients with unaffected parents. Two de novo mutations (R1117X and R536W) were identified in two families, one being found in three affected brothers, suggesting germline mosaicism. Zebrafish and rat hippocampal neuron assays revealed behavior and differentiation defects resulting from the R1117X mutant. As mutations in SHANK3 were previously reported in autism, the occurrence of SHANK3 mutations in subjects with a schizophrenia phenotype suggests a molecular genetic link between these two neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have also been identified in individuals developing adult-onset SHANK3 related-disorders, such as schizophrenia and bipolar disorders 96,97”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [97]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functional studies have confirmed that this mutation causes a loss of SHANK3 function in zebrafish and decreases neurite outgrowth in mice.50”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the case of schizophrenia, the de novo mutation R1117X with germline mosaicism has been observed in three affected brothers.”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, point mutations, including a nonsense mutation in exon 21 (p.R1117X) of SHANK3 have been reported in families with schizophrenia and mild intellectual disability (Gauthier et al., 2010).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Gauthier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have been identified in patients suffering from schizophrenia and bipolar disorder [45], [47].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [47]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577 · cited 3×
“Bromberg Y, Rost B (2007) SNAP: Predict effect of non-synonymous polymorphisms on function.”
BackgroundAdaptive protein evolution at the Adh locus in Drosophila
McDonald, J. H., & Kreitman, M. (1991) · Nature · doi:10.1038/351652a0 · Cited by 3,283 · cited 2×
“To evaluate whether SHANK3 is accumulating deleterious mutations in human populations, we performed a standard population genetic test (14) which asks whether there is an excess of potentially disruptive amino acid mutations accumulating at this locus more so than expected by chance (Table S4).”
BackgroundHuman non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745 · cited 1×
“Interestingly, recent studies reported de novo copy-number variants in SCZ, providing further support for the de novo mutation hypothesis (5, 6).”
ResultDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 3×
“Deleterious SHANK3 mutations have previously been reported in ASD (7, 8, 32), suggesting that the phenotypic spectrum of such mutations is rather broad.”
BackgroundAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464 · cited 1×
“To exclude a possible diagnosis of autism, the Autism Screening Questionnaire (10) was completed and her score was 1 (score> 15= autism).”
BackgroundMapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Prediction of deleterious human alleles
Sunyaev, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,044
SNAP: predict effect of non-synonymous polymorphisms on function
Bromberg, Y., & Rost, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm238 · Cited by 863
Research works printed but not linked: 1
- Goslin K, Asmussen H, Banker G. Rat hippocampal neurons in low-density culture. In: Banker G, Goslin K, editors. Culturing Nerve Cells. Cambridge, MA: MIT Press; 1998. [Google Scholar]
Cited by
Items 101–200 of 371
Kolevzon, A., Delaby, E., Berry‐Kravis, E., Buxbaum, J. D., & Betancur, C. (2019) · Molecular Autism · doi:10.1186/s13229-019-0291-3 · Cited by 93
“…16 17 18 Reference Durand et al. (2007) [2] Durand et al. (2007) [2] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Subject Family ASD 2 (eldest brother) Family ASD 2 (youngest brother) Family PED 419, subject II-1 (eldest brother)…”
BackgroundInfluentialPhelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment
Harony-Nicolas, H., De Rubeis, S., Kolevzon, A., & Buxbaum, J. D. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600872 · Cited by 81
Mowry, B. J., & Gratten, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.34 · Cited by 92
Somers, M., Ophoff, R. A., Aukes, M. F., Cantor, R. M., Boks, M. P., Dauwan, M., Visser, K., Kahn, R. S., & Sommer, I. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3287-14.2015 · Cited by 85
Grabrucker, A. M., Schmeisser, M. J., Udvardi, P. T., Arons, M., Schoen, M., Woodling, N. S., Andreasson, K. I., Hof, P. R., Buxbaum, J. D., Garner, C. C., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-65 · Cited by 76
Translational Concepts of mGluR5 in Synaptic Diseases of the Brain
Piers, T. M., Kim, D. H., Kim, B. C., Regan, P., Whitcomb, D. J., & Cho, K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00199 · Cited by 77
Neurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeisser, M. J., Krueger, D. D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 75
“…deleterious SHANK3 mutations in patients with ASD and moreover in patients with other neurodevelopmental disorders such as intellectual disability, schizophrenia, and bipolar disorder (Moessner et al. 2007; Gauthier et al. 2009, 2010; Hamdan et al. 2011; Denayer et al. 2012; Boccuto et al. 2012).”
BackgroundBerridge, M. J. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00188.2017 · Cited by 81
Cell Biology of the BLOC-1 Complex Subunit Dysbindin, a Schizophrenia Susceptibility Gene
Mullin, A. P., Gokhale, A., Larimore, J. L., & Faúndez, V. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8183-3 · Cited by 79
“These include copy number variations such as chromosome microdeletions or microduplications [11–17]; chromosomal translocations comprising the DISC1 locus [18]; and mutations affecting the postsynaptic scaffolding protein Shank3 [19] or a kinesin motor isoform [20].”
BackgroundEmerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders
Torres, V. I., Vallejo, D., & Inestrosa, N. C. (2017) · Neural Plasticity · doi:10.1155/2017/8081758 · Cited by 76
“The Shank3 mutations, R1117X and R536W, have been observed in patients with SCZ associated with ID [197].”
BackgroundSungur, A. Ö., Vörckel, K. J., Schwarting, R. K. W., & Wöhr, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.05.003 · Cited by 81
Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome
Mitz, A. R., Philyaw, T. J., Boccuto, L., Shcheglovitov, A., Sarasua, S. M., Kaufmann, W. E., & Thurm, A. E. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0042-x · Cited by 79
“16% [15, 16], making it an important target for possible pharmacological intervention in these major neuropsychiatric and neurodevelopmental disorders.”
BackgroundSchizophrenia Related Variants in CACNA1C also Confer Risk of Autism
Li, J., Zhao, L., You, Y., Lu, T., Jia, M., Yu, H., Ruan, Y., Yue, W., Liu, J., Lu, L., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133247 · Cited by 68
“The susceptibility genes (such as DISC1 [33,34], RELN [35,36], GABA [37–39], SHANK3 [40,41], NRXN1 [20,42], NTNG1 [43,44], etc.), which were associated with schizophrenia, also confer risk to ASD.”
Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers
Pappas, A. L., Bey, A. L., Wang, X., Rossi, M., Kim, Y. H., Yan, H., Porkka, F., Duffney, L. J., Phillips, S. M., Cao, X., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92052 · Cited by 67
Plasma antioxidant capacity is reduced in Asperger syndrome
Parellada, M., Moreno, C., MacDowell, K. S., Leza, J. C., Giráldez, M., Bailón, C., Castro, C., Miranda-Azpiazu, P., Fraguas, D., & Arango, C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.10.004 · Cited by 74
The PHF21B gene is associated with major depression and modulates the stress response
Wong, M., Arcos‐Burgos, M., Liu, S., Velez, J. I., Yu, C., Baune, B. T., Jawahar, M. C., Arolt, V., Dannlowski, U., Chuah, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.174 · Cited by 67
Gouder, L., Vitrac, A., Goubran-Botros, H., Danckaert, A., Tinevez, J.-Y., André-Leroux, G., Atanasova, E., Lemière, N., Biton, A., Leblond, C. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36993-x · Cited by 65
Lateral organization of the postsynaptic density
MacGillavry, H. D., Kerr, J. M., & Blanpied, T. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.09.001 · Cited by 66
“In the case of the PSD, Shank3 genetic mutations and deletions are linked to autism spectrum and other neurodevelopmental disorders (Bonaglia et al., 2001; Durand et al., 2007) as well as schizophrenia (Gauthier et al., 2010).”
BackgroundInter-Individual and Inter-Strain Variations in Zebrafish Locomotor Ontogeny
Lange, M., Neuzeret, F., Fabrèges, B., Froc, C., Bedu, S., Bally‐Cuif, L., & Norton, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070172 · Cited by 70
“Reduced locomotion following touch has also been used to assess the function of SHANK3, a gene which is connected to autism spectrum disorder in humans [15].”
MethodInfluentialGrabrucker, S., Proepper, C., Mangus, K., Eckert, M., Chhabra, R., Schmeißer, M. J., Boeckers, T. M., & Grabrucker, A. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.015 · Cited by 78
“, 2012), ProSAP2/Shank3 (Gauthier et al., 2010), proteins of the Synaptotagmin family and Leucine-rich repeat transmembrane neuronal protein 1 (LRRTM1) (Inoue et al.”
BackgroundInfluentialSynapse development in health and disease
Melom, J. E., & Littleton, J. T. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.002 · Cited by 63
Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing
Kumita, W., Sato, K., Suzuki, Y., Kurotaki, Y., Harada, T., Zhou, Y., Kishi, N., Sato, K., Aiba, A., Sakakibara, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49110-3 · Cited by 67
Soler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 71
Self-citationZirn, B., Arning, L., Bartels, I., Shoukier, M., Hoffjan, S., Neubauer, B., & Hahn, A. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01598.x · Cited by 63
Piton, A., Jouan, L., Rochefort, D. L., Dobrzeniecka, S., Lachapelle, K., Dion, P. A., Gauthier, J., & Rouleau, G. A. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.243 · Cited by 73
Self-citationde Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 65
De Novo Mutation in Schizophrenia
Rees, E., Kirov, G., O'Donovan, M. C., & Owen, M. J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs047 · Cited by 57
Autism spectrum disorder and schizophrenia: boundaries and uncertainties
Pina‐Camacho, L., Parellada, M., & Kyriakopoulos, M. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.014720 · Cited by 66
“There is also some evidence that de novo mutations in the same genes (e.g. SHANK3 ) could account for a number of cases of schizophrenia (Gauthier 2010) and ASD (Durand 2007).”
Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction
Perfitt, T. L., Wang, X., Dickerson, M. T., Stephenson, J. R., Nakagawa, T., Jacobson, D. A., & Colbran, R. J. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0893-19.2020 · Cited by 54
Cerebral organoids as tools to identify the developmental roots of autism
Chan, W. K., Griffiths, R., Price, D. J., & Mason, J. O. (2020) · Molecular Autism · doi:10.1186/s13229-020-00360-3 · Cited by 62
“Subsequently, SHANK3 mutations have been found in numerous ASD patients [37, 50, 95].”
BackgroundIasevoli, F., Tomasetti, C., Buonaguro, E. F., & de Bartolomeis, A. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140324183406 · Cited by 58
“All Authors state they have no conflict of interest in this work.”
BackgroundWu, Y., Liu, X., Luo, H., Deng, W., Zhao, G., Wang, Q., Zhang, L., Ma, X., Liu, X., Murray, R. M., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.020 · Cited by 55
Amiet, C., Gourfinkel-An, I., Laurent, C., Bodeau, N., Génin, B., Leguern, E., Tordjman, S., & Cohen, D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-47 · Cited by 52
“3 Deletion De novo ASD, ID, SCZ Synapse scaffolding [53,54]”
BackgroundEltokhi, A., Santuy, A., Merchán-Pérez, Á., & Sprengel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010059 · Cited by 60
Updated consensus guidelines on the management of Phelan–McDermid syndrome
Srivastava, S., Şahin, M., Buxbaum, J. D., Berry‐Kravis, E., Soorya, L. V., Thurm, A. E., Bernstein, J. A., Asante‐Otoo, A., Bennett, W. E., Betancur, C., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63312 · Cited by 55
“There are reports of four families with multiple affected siblings with SHANK3 variants, consistent with gonadal mosaicism in one of the parents (Durand et al., 2007; Gauthier et al., 2010; Nemirovsky et al., 2015; Nevado et al., 2022).”
BackgroundIn the swim of things: recent insights to neurogenetic disorders from zebrafish
Kabashi, E., Champagne, N., Brustein, E., & Drapeau, P. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.004 · Cited by 62
Self-citationSHANK3,the Synapse, and Autism
Herbert, M. R. (2011) · New England Journal of Medicine · doi:10.1056/nejmcibr1104261 · Cited by 50
Neurogenetics: Advancing the “Next-Generation” of Brain Research
Zoghbi, H. Y., & Warren, S. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.015 · Cited by 48
Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases
Sundararajan, T., Manzardo, A. M., & Butler, M. G. (2017) · Gene · doi:10.1016/j.gene.2017.10.035 · Cited by 59
“Further evidence supports SHANK3 mutations linked to SCZ and overexpression in manic-like behaviors (Gauthier et al., 2010; Han et al., 2013).”
BackgroundNeurodevelopmental Origins of Schizophrenia
Weinberger, D. R., & Levitt, P. (2010) · Schizophrenia · doi:10.1002/9781444327298.ch19 · Cited by 49
Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish
McCammon, J. M., & Sive, H. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019620 · Cited by 55
“For example, Gauthier and colleagues showed that a rare variant of SH3 and multiple ankyrin repeat domains 3 (SHANK3) associated with schizophrenia could not rescue head size and swimming deficits in a zebrafish shank3 LOF embryo, whereas a second variant and wild-type RNA could (Gauthier et al., 2010), suggesting tha…”
Merner, N. D., Mercado, A., Khanna, A. R., Hodgkinson, A., Bruat, V., Awadalla, P., Gamba, G., Rouleau, G. A., & Kahle, K. T. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.016 · Cited by 49
Self-citationShank Proteins Differentially Regulate Synaptic Transmission
Shi, R., Redman, P. T., Ghose, D., Hwang, H., Liu, Y., Ren, X., Ding, L. J., Liu, M., Jones, K. J., & Xu, W. (2017) · eNeuro · doi:10.1523/eneuro.0163-15.2017 · Cited by 56
Yoo, T., Cho, H., Lee, J., Park, H., Yoo, Y.-E., Yang, E., Kim, J. Y., Kim, H., & Kim, E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00341 · Cited by 46
“…intellectual disability and mania (Phelan et al., 1993; Bonaglia et al., 2001; Wilson et al., 2003; Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2010; Bonaglia et al., 2011; Hamdan et al., 2011; Leblond et al., 2012; Boccuto et al., 2013; Frontiers in Cellular Neuroscience |…”
BackgroundLee, Y., Kim, S. G., Lee, B., Zhang, Y., Kim, Y., Kim, S., Kim, E., Kang, H., & Han, K. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00201 · Cited by 49
“…to duplications, deletions and various point mutations of SHANK3 gene have been causally associated with ASDs, ID and SCZ (Durand et al., 2007; Gauthier et al., 2010; Grabrucker et al., 2011; Jiang and Ehlers, 2013; Guilmatre et al., 2014; Leblond et al., 2014; Choi et al., 2015; Monteiro and…”
BackgroundJin, Z., Li, Z., Liu, Z., Jiang, Y. W., Cai, X., & Wu, J. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12383 · Cited by 55
“Indeed, DNMs have recently been identified as important contributors to sporadic cases of a range of human genetic disorders, including autism spectrum disorder (ASD) (O’Roak et al., 2011, 2012b; Iossifov et al., 2012; Neale et al., 2012; Sanders et al., 2012), schizophrenia (SCZ) (Girard et al., 2011; Xu et al., 2011…”
BackgroundInfluentialMatosin, N., Fernandez, F., Lum, J. S., & Newell, K. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.003 · Cited by 52
Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion
Vucurovic, K., Landais, E., Delahaigue, C., Eutrope, J., Schneider, A., Leroy, C., Kabbaj, H., Motte, J. E., Gaillard, D. A., Rolland, A.-C., et al. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.07.009 · Cited by 52
Gong, X., Jiang, Y.-W., Zhang, X., An, Y., Zhang, J., Wu, Y., Wang, J., Sun, Y., Liu, Y., Gao, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034739 · Cited by 46
Merner, N., Forgeot d'Arc, B., Bell, S. C., Maussion, G., Peng, H., Gauthier, J., Crapper, L., Hamdan, F. F., Michaud, J. L., Mottron, L., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37566 · Cited by 46
“The three disease cohorts, autism, schizophrenia (SCZ), and intellectual disability (ID), were established as part of the Synapse to Disease project [Gauthier et al., 2005; Hamdan et al., 2009; Awadalla et al., 2010; Gauthier et al., 2010].”
BackgroundSelf-citationAn, Y., Zhang, L., Liu, W., Jiang, Y., Xue, C., Lan, X., Li, G., Hang, Q., Wang, J., Gusella, J. F., et al. (2020) · Human Genetics · doi:10.1007/s00439-020-02115-9 · Cited by 50
Genetics of Childhood-onset Schizophrenia
Asarnow, R. F., & Forsyth, J. K. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.06.004 · Cited by 48
Alisch, R. S., Chopra, P., Fox, A. S., Chen, K., White, A. T. J., Roseboom, P. H., Keles, S., & Kalin, N. H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3338-14.2014 · Cited by 45
Fujita‐Jimbo, E., Tanabe, Y., Yu, Z., Kojima, K., Mori, M., Li, H., Iwamoto, S., Yamagata, T., Momoi, M. Y., & Momoi, T. (2015) · Molecular Autism · doi:10.1186/s13229-015-0012-5 · Cited by 51
“Mutations in NRXN1, NRXN2, NLGN2, NLGN4, and SHANK3 genes related to ASD have been also found in schizophrenia patients [10-13].”
BackgroundAn opposing function of paralogs in balancing developmental synapse maturation
Favaro, P. D., Huang, X., Hosang, L., Stodieck, S. K., Cui, L., Liu, Y.-Z., Engelhardt, K.-A., Schmitz, F., Dong, Y., Löwel, S., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006838 · Cited by 47
Heredity in epilepsy: Neurodevelopment, comorbidity, and the neurological trait
Johnson, M. R., & Shorvon, S. D. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.07.031 · Cited by 52
“In contrast, deep sequencing of other candidate genes affected by copy number variation have identified private mutations in the synaptic scaffolding gene SHANK3 in sporadic schizophrenia [58] and SHANK2 in autism/mental retardation [59], among others, suggesting that deletion at least for some genes”
BackgroundLennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., Schulze‐Rauschenbach, S., Landsberg, M. W., Steinbrecher, A., Alexander, M., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0233-3 · Cited by 47
An examination of multiple classes of rare variants in extended families with bipolar disorder
Toma, C., Shaw, A. D., Allcock, R. J. N., Heath, A., Pierce, K. D., Mitchell, P. B., Schofield, P. R., & Fullerton, J. M. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0113-y · Cited by 48
Yoo, Y.-E., Yoo, T., Lee, S., Lee, J., Kim, D., Han, H.-M., Bae, Y.-C., & Kim, E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00155 · Cited by 44
“…(PMS), schizophrenia, intellectual disability, and mania (Bonaglia et al., 2001; Wilson et al., 2003; Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2010; Bonaglia et al., 2011; Hamdan et al., 2011; Leblond et al., 2012; Boccuto et al., 2013; Han et al., 2013; Guilmatre et al.,…”
BackgroundYoo, T., Cho, H., Park, H., Lee, J., & Kim, E. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00458 · Cited by 49
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
“3 deletion syndrome also known as the Phelan–McDermid syndrome (PMDS), which results from Shank 3 haploinsufficiency or heterozygous Shank 3 missense variants [166–170].”
BackgroundSchizophrenia Genetics: Putting All the Pieces Together
Girard, S., Dion, P. A., & Rouleau, G. A. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0266-7 · Cited by 54
Self-citationSynapse-to-nucleus communication: from developmental disorders to Alzheimer's disease
Marcello, E. E., Luca, M. D., & Gardoni, F. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.017 · Cited by 44
Xu, N., Lv, H., Yang, T., Du, X., Sun, Y., Xiao, B., Fan, Y., Luo, X., Zhan, Y., Wang, L., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01592-5 · Cited by 43
Addington, A. M., & Rapoport, J. L. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02478.x · Cited by 45
Self-citationClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders
Kim, K. C., Gonzales, E. L., Lázaro, M. T., Choi, C. S., Bahn, G. H., Yoo, H. J., & Shin, C. Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.061 · Cited by 48
Investigation of SHANK3 in schizophrenia
Cortabitarte, A. D. S., Degenhardt, F., Strohmaier, J., Lang, M., Weiß, B., Roeth, R., Giegling, I., Heilmann‐Heimbach, S., Hofmann, A., Rujescu, D., et al. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32528 · Cited by 49
“…selection criteria were used: (i) significant association after Bonferroni correction; (ii) missense variant of putative functional relevance reported in an independent SHANK3 Sanger sequencing study in SCZ patients [Gauthier et al., 2010]; or (iii) predicted functional relevance in the 30UTR.”
BackgroundMethodResultInfluentialSHANK genes in autism: Defining therapeutic targets
Mossa, A., Giona, F., Pagano, J., Sala, C., & Verpelli, C. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.019 · Cited by 46
Addressing the Genetics of Human Mental Health Disorders in Model Organisms
McCammon, J. M., & Sive, H. L. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050048 · Cited by 44
Are Circadian Disturbances a Core Pathophysiological Component of Schizophrenia?
Delorme, T. C., Srivastava, L. K., & Cermakian, N. (2020) · Journal of Biological Rhythms · doi:10.1177/0748730420929448 · Cited by 50
Zebrafish as a genomics model for human neurological and polygenic disorders
Becker, T. S., & Rinkwitz, S. (2012) · Developmental Neurobiology · doi:10.1002/dneu.20888 · Cited by 42
“The X-chromosomal SHANK3 encodes a scaffolding protein expressed in the postsynaptic density of excitatory synapses on dendritic spines, and mutations in this gene have been identified in patients with schizophrenia (Gauthier et al., 2010).”
BackgroundWan, L., Ai, J.-Q., Yang, C. G., Jiang, J., Zhang, Q., Luo, Z., Huang, R., Tu, T., Pan, A., Tu, E., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717263 · Cited by 40
“…al., 1985; Bonaglia et al., 2006, 2011; Toro et al., 2010; Phelan and McDermid, 2012; Zwanenburg et al., 2016), schizophrenia (Failla et al., 2007; Gauthier et al., 2010; de Sena Cortabitarte et al., 2017), and bipolar disorder (Denayer et al., 2012; Vucurovic et al., 2012; Crisafulli et al.,…”
BackgroundGenetic studies of schizophrenia: an update
Chen, J., Cao, F., Liu, L., Wang, L., & Chen, X. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1494-4 · Cited by 45
Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders
Li, Y., Jia, X., Wu, H., Xun, G., Ou, J., Zhang, Q., Li, H., Bai, T., Hu, Z., Zou, X., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40666 · Cited by 43
A critical review of zebrafish schizophrenia models: Time for validation?
Gaweł, K., Banono, N. S., Michalak, A., & Esguerra, C. V. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.001 · Cited by 41
Yan, L., Zhou, J., Wang, D., Si, D., Liu, Y., Zhong, L., & Yin, Y. (2018) · Metabolomics · doi:10.1007/s11306-018-1375-3 · Cited by 36
Lee, Y., Kang, H., Lee, B., Zhang, Y., Kim, Y., Kim, S., Kim, W.-K., & Han, K. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00110 · Cited by 42
“Importantly, Zhou et al. (2016) recently demonstrated that two different Shank3 knock-in (KI) mice modeling the human mutations of ASD (InsG3680) and SCZ (R1117X) display STR- and PFC-specific synaptic defects, respectively.”
BackgroundInfluentialOxytocin and Animal Models for Autism Spectrum Disorder
Wagner, S., & Harony‐Nicolas, H. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_15 · Cited by 44
Endo, R., Takashima, N., Nekooki-Machida, Y., Komi, Y., Hui, K. K., Takao, M., Akatsu, H., Murayama, S., Sawa, A., & Tanaka, M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.03.008 · Cited by 37
“Among these, Shank3 is a scaffold protein that organizes macromolecular complexes at the postsynapse (51) and a mutation in SHANK3 is strongly linked to psychiatric disorders including schizophrenia and autism spectrum disorders (52,53).”
MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis
Zhang, J., Sun, X., & Zhang, L.-Y. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.01.031 · Cited by 38
“Considering that mutations in SHANK3 were previously reported in autism, the identification of SHANK3 mutations in patients with schizophrenia suggests that a similar molecular genetic mechanism might govern both those two neurodevelopmental disorders [10].”
BackgroundKas, M. J., Krishnan, V., Gould, T. D., Collier, D. A., Olivier, B., Lesch, K., Domenici, E., Fuchs, E., Gross, C. T., & Ċastrén, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.12.001 · Cited by 38
Currently recognized genes for schizophrenia: High‐resolution chromosome ideogram representation
Butler, M. G., McGuire, A., Masoud, H., & Manzardo, A. M. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32391 · Cited by 37
Pescosolido, M. F., Uzun, E. D. G., Nagpal, S., & Morrow, E. M. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.01.003 · Cited by 42
The Neurological Manifestations of Phelan-McDermid Syndrome
Frank, Y. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.06.002 · Cited by 40
Kolevzon, A., Cai, G., Soorya, L. V., Takahashi, N., Grodberg, D., Kajiwara, Y., Willner, J. P., Tryfon, A., & Buxbaum, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.005 · Cited by 32
Gadow, K. D., & DeVincent, C. J. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1473-4 · Cited by 36
Kébir, O., Chaumette, B., Fatjó‐Vilas, M., Ambalavanan, A., Ramoz, N., Xiong, L., Mouaffak, F., Millet, B., Jaafari, N., DeLisi, L. E., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.029 · Cited by 35
“We considered the regions for all the HDAC genes in a total of 1134 exomes and the variant calling was performed using Genome Analysis Tool Kit (GATK) as part of the S2D project detailed elsewhere (Gauthier et al., 2010; Tarabeux et al., 2011).”
MethodSelf-citationCammarata-Scalisi, F., Callea, M., Martinelli, D., Willoughby, C. E., Tadich, A. C., Castillo, M. A., Lacruz-Rengel, M. A., Medina, M., Grimaldi, P., Bertini, E., et al. (2022) · Genes · doi:10.3390/genes13030504 · Cited by 37
Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes
Peall, K. J., Owen, M. J., & Hall, J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00896-x · Cited by 37
“Pathogenic SHANK3 variants have also been identified in two families from a cohort of 185 individuals with a diagnosis of schizophrenia; the reported clinical phenotype included intellectual difficulties, seizures, speech impairment and atypical psychosis 98 .”
Developmental convergence and divergence in human stem cell models of autism
Gordon, A., Yoon, S., Bicks, L. K., Martín, J. M., Pintacuda, G., Arteaga, S. A., Wamsley, B., Guo, Q., Elahi, L. S., Dolmetsch, R. E., et al. (2026) · Nature · doi:10.1038/s41586-025-10047-5 · Cited by 52
Liu, C., Peng, X., Hu, C.-C., Li, C., Li, Q., & Xu, X. (2016) · Development Genes and Evolution · doi:10.1007/s00427-016-0561-4 · Cited by 39
“The sequences of the newly identified splice variants were annotated and deposited into the Ensembl database.”
BackgroundMethodInfluentialAutism, Psychosis, or Both? Unraveling Complex Patient Presentations
Chandrasekhar, T., Copeland, J. N., Spanos, M., & Sikich, L. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.003 · Cited by 32
Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk
Kranz, T. M., Goetz, R. R., Walsh‐Messinger, J., Goetz, D. M., Antonius, D., Dolgalev, I., Heguy, A., Seandel, M., Malaspina, D., & Chao, M. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.002 · Cited by 35
“SHANK3 is a scaffold protein that interacts with the cytoskeleton and also with PSD-95 and glutamate receptors (Gauthier et al., 2010; Gauthier et al., 2009).”
BackgroundNeurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap
Kimoto, S., Makinodan, M., & Kishimoto, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.022 · Cited by 34
Risk genes for schizophrenia: Translational opportunities for drug discovery
Winchester, C. L., Pratt, J. A., & Morris, B. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.003 · Cited by 34
Xue, C.-B., Xu, Z.-H., Zhu, J., Wu, Y., Zhuang, X.-H., Chen, Q.-L., Wu, C., Jintao, H., Zhou, H.-S., Xie, W.-H., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00725 · Cited by 31
“…studies in schizophrenia,1 only a few genes have been mapped in these loci, such as PRODH (SCZD4) (Jacquet et al., 2002), DISC1 (SCZD9) (Debono et al., 2012, 1), SHANK3 (SCZD15) (Gauthier et al., 2010), NRXN1 (SCZD17) (Rujescu et al., 2009), and SLC1A1 (SCZD18) (Myles-Worsley et al., 2013, 1).”
BackgroundMolecular architecture of postsynaptic Interactomes
Wilkinson, B., & Coba, M. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109782 · Cited by 30
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date
Fung, L. K., & Hardan, A. Y. (2015) · CNS Drugs · doi:10.1007/s40263-015-0252-0 · Cited by 30
Is insulin growth factor-1 the future for treating autism spectrum disorder and/or schizophrenia?
Khalil, R. B. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.12.004 · Cited by 31
Viñas‐Jornet, M., Esteba‐Castillo, S., Baena, N., Ribas‐Vidal, N., Ruiz, A., Torrents‐Rodas, D., Gabau, E., Vilella, E., Martorell, L., Armengol, L., et al. (2018) · Behavior Genetics · doi:10.1007/s10519-018-9902-6 · Cited by 28
Metadata
- Authors
- Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., Hamdan, F. F., Addington, A. M., Rapoport, J. L., DeLisi, L. E., Krebs, M.-O., Joober, R., Fathalli, F., Mouaffak, F., Haghighi, A. P., Néri, C., Dubé, M.-P., Samuels, M. E., Marineau, C., Stone, E. A., Awadalla, P., Barker, P. A., Carbonetto, S., Drapeau, P., Rouleau, G. A., the S2D Team, Daignault, K., Diallo, O., Duguay, J., Drits, M., Henrion, E., Jolivet, P., Kuku, F., Lachapelle, K., Laliberté, G., Laurent, S., Liao, M., Marino, C., Piton, A., Raymond, A., Reynolds, A., Rochefort, D., St-Onge, J., Thibodeau, P., Tsurudome, K., Yang, Y., Leroy, S., Ossian, K., Chayet, M., & Gourion, D.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1600;
- National Institute of Mental Health (US)
- Harvard University (US)
- Centre Hospitalier Sainte-Anne (FR)
- Douglas Mental Health University Institute (CA)
- McGill University (CA)
- Inserm (FR)
- Montreal Heart Institute (CA)
- North Carolina State University (US)
- Montreal Neurological Institute and Hospital (CA)
- Montreal General Hospital (CA)
- ORCID
- Xiong, Lan
- Spiegelman, Dan
- Hamdan, Fadi F.
- DeLisi, Lynn E.
- Krebs, Marie-Odile
- Joober, Ridha
- Mouaffak, Fayçal
- Haghighi, Ali P.
- Néri, Christian
- Dubé, Marie-Pierre
- Samuels, Mark E.
- Stone, Eric A.
- Awadalla, Philip
- Barker, Philip A.
- Drapeau, Pierre
- Rouleau, Guy A.
- Jolivet, Philippe
- Liao, Meijiang
- Piton, Amélie
- Rochefort, Daniel
- Leroy, Sophie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-12
- Volume
- 107
- Issue
- 17
- Pages
- 7863-7868
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2867875
- OpenAlex
- W1978075999
- Cited by
- 369
- References
- 41
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 19 · 2023: 20 · 2022: 9 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 25 · 2017: 24 · 2016: 22 · 2015: 38 · 2014: 22 · 2013: 29 · 2012: 40
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Génome Québec
- Université de Montréal
- Fondation Pierre Deniker pour la Recherche et la Prévention en Santé Mentale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- schizophrenia, SHANK3, de novo mutations, germline mosaicism, synaptic scaffolding proteins, neurodevelopmental disorders, autism spectrum disorder, hippocampal neurons, zebrafish, rats, behavioral defects, neuronal differentiation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, Female, Humans, Male, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Pedigree, Schizophrenia, Zebrafish, Sequence Analysis, DNA, DNA Primers, Microsatellite Repeats, Computational Biology, Mutation, Missense, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.